The Central Drug Standard Control Organization through notice dated 19 August, 2021 has extended the due date for submission of information regarding certain pre-1988 permitted fixed dose combinations de novo for manufacture for sale in the country for evaluation.
The Due date for submission of such information previously requested by CDSCO is extended from 25.08.2021 to 25.10.2021.